Clinical Trial Detail

NCT ID NCT02019069
Title CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bruno C. Medeiros
Indications

acute myeloid leukemia

myelodysplastic syndrome

Therapies

CPX-351

Age Groups:

No variant requirements are available.